Equine coronaviruses (ECoV) are the only coronavirus known to infect horses. So far, data on ECoV infection in horses remain limited to the USA, France and Japan and its geographic distribution is not well understood. We carried out RT-PCR on 306 nasal and 315 rectal swabs and tested 243 sera for antibodies to detect coronavirus infections in apparently healthy horses in Saudi Arabia and Oman. We docu- 
infect or cause disease in horses (Balasuriya, 2013) . It belongs to the genus Betacoronavirus lineage A, as does human coronavirus OC43, bovine coronavirus and porcine hemagglutinating encephalomyelitis virus. Equine coronavirus was first isolated from faeces of a diarrhoeic foal in 1999 (ECoV-NC99) in North Carolina, USA (Guy, Breslin, Breuhaus, Vivrette, & Smith, 2000) , and was initially believed to only affect foals. Since 2010, there have been several reports of ECoV-associated respiratory and enteric infections in adult horses in Japan, Europe and the United States, but its global distribution is still poorly defined (Kooijman, Mapes, & Pusterla, 2016; Miszczak et al., 2014; Oue, Morita, Kondo, & Nemoto, 2013; Pusterla, Holzenkaempfer, Mapes, & Kass, 2015) .
Middle East respiratory syndrome coronavirus (MERS-CoV) is a betacoronavirus within lineage C first identified in humans in 2012 and continues to pose a threat to global health (WHO, 2016 May 27) . The evidence points to dromedary camels as a natural host and a major source for human MERS-CoV infections (Alexandersen, Kobinger, Soule, & Wernery, 2014; Chu et al., 2015; Gutierrez, Tejedor-Junco, Gonzalez, Lattwein, & Renneker, 2015; Memish et al., 2014; Perera et al., 2013; Reusken et al., 2014) . There is no convincing evidence of MERS-CoV infections in other domestic livestock species so far (Adney et al., 2016; Alexandersen et al., 2014; Hemida et al., 2013; Meyer et al., 2015; Perera et al., 2013) .
Sequence similarity comparisons of dipeptidyl peptidase-4 (DPP4
[CD26]), the functional receptor for MERS-CoV, have revealed that equine DPP4 is phylogentically closely related to human DPP4 and the binding affinity of MERS-CoV spike S1 domain for equine DPP4 is similar to that of human and camel DPP4, raising the possibility that MERS-CoV infections may occur among horses (Barlan et al., 2014) . Serological studies of horses originating from Spain and the United Arab Emirates gave negative results for MERS-CoV (Alexandersen et al., 2014; Meyer et al., 2015) , but it is still relevant to investigate for evidence of MERS-CoV in horses in areas endemic for MERS-CoV.
We have tested for coronavirus infections in apparently healthy horses in Saudi Arabia and Oman by testing nasal and rectal swabs by RT-PCR assays for MERS-coronavirus and using a pan-coronavirus RT-PCR with potential to detect all coronaviruses, hitherto known and unknown. Following the detection of ECoV and HKU23 coronavirus (HKU23) by the pan-coronavirus RT-PCR, we tested the swab specimens with specific RT-PCR assays for ECoV and HKU23 and tested the sera with serological assays to detect ECoV, bovine CoV (BCoV) (closely related to HKU23), as well as MERS-CoV.
| MATERIALS AND METHODS

| Specimen collection
Serum samples (n = 243), nasal swabs (n = 306) and rectal swabs (n = 315) were collected from apparently healthy adult (>1 years of age) horses from East and Central provinces of the Kingdom of Saudi Arabia and Oman. Many horses had all three samples collected. These specimens were collected during the period February 2014 to January 2015. The numbers of specimens collected from different geographic regions of Saudi Arabia and Oman are indicated in (Guy et al., 2000; Zhang et al., 2007) and the bovine coronavirus (ATCC BRCV-OK-0514-2).
| RT-PCR testing
Viral RNA was extracted from nasal and rectal swabs using the QIAamp viral RNA minikit (Qiagen, Hilden, Germany) following the manufacturer's instructions. RNA extracts were tested for evidence of conserved coronavirus nucleic acid genetic sequences using previously reported RT-PCR assays (Chu et al., 2014) , RTqPCR assay for MERS-CoV upE gene (Corman et al., 2012) , RTqPCR assay for ECoV (Miszczak et al., 2014) , and a RTqPCR assay for HKU23 reported below. RNA was reverse transcribed in a 20 ll reaction mixture containing 19 first-strand buffer, 5 mM DTT, 0.5 mM deoxynucleotide triphosphates (dNTP), 2.5 ng/ll random hexamers and 200 units of SuperScript III (Life Technologies).
The pan-coronavirus nested PCR targeted the RNA-dependent RNA polymerase (RdRp) gene of coronaviruses developed by us as previously described (Chu et al., 2014) . Using the cDNA synthesized as described above, first round PCR was carried out using forward The details of all RT-PCR and real-time PCR assays used in this study are summarized in Table S1 .
| PCR amplicon sequencing and analysis
The primers used for sequencing were those used to generate the PCR products. DNA amplicons were purified and sequenced in both forward and reverse directions with the PCR primers using BigDye 
| Serology
All sera were tested using previously validated MERS-CoV spike pseudoparticle neutralization test (ppNT) (Hemida et al., 2014; Perera et al., 2013) , and the positive sera were confirmed using microneutralization (MN) test and plaque reduction neutralization tests (PRNT) using live MERS-CoV strain EMC in a Biosafety Level 3 containment laboratory (Park et al., 2015) . Selected sera were tested for antibodies to ECoV and BCoVs . The North American ECoV- The virus-serum mixture was then added in quadruplicate to HRT-18G cell monolayers in 96-well microtitre plates followed by 1 hr adsorption at 37°C. The plates were incubated at 37°C in 5% CO 2 in a humidified incubator for 5 days, when virus back titrations were inspected to confirm that the virus dose used was within the expected range. The antibody titre was the highest serum dilution that resulted in complete neutralization of cytopathic effect in ≥2 of the four wells replicate wells at each serum dilution. Antibody titre refers to the dilution of the serum in the serum dilution-virus mixture. All antibody titres are denoted as the reciprocal of the titre.
BCoV is ubiquitous in cattle worldwide and is genetically and antigenically related with HKU23, a coronavirus endemic in dromedaries (Woo et al., 2014 (Woo et al., , 2016 . Antibody to BCoV was tested using MN assay as described previously (Park et al., 2015; Perera et al., 2013) . Serology for BCoV and ECoV was carried out with culture medium without foetal calf serum. Known positive and negative control sera were included in all serology assays.
| Reference sera used in investigation of crossreactivity in serological assays
Cross-reactive responses in the MERS-CoV ppNT, BCoV MN and ECoV MN assays were assessed using a panel of previously characterized immune or hyperimmune reference antisera generated against alpha, beta and gamma coronaviruses. These sera were either were also obtained, where available, from the providers of these respective antisera. The serum panel for alpha coronavirus included sera generated against porcine respiratory coronavirus, feline infectious peritonitis virus, canine enteric coronavirus and porcine transmissible gastroenteritis virus. Sera produced against mouse hepatitis virus strains JHM and A59, SARS coronavirus, BCoV, ECoV represented the betacoronavirus group. Furthermore, an immune serum for infectious bronchitis virus was used as representative for the gammacoronavirus group. All these reference sera, as well as additional ECoV immune sera and MERS-CoV-negative camel sera, were tested in ppNT or MN assays in parallel against MERS-CoV, BCoV, as well as ECoV, to assess possible cross-reactive antibody responses among these three coronaviruses. Some of these reference sera, with the exception of horse and camel sera, had been previously tested against MERS-CoV and BCoV, and the results were reported by us (Hemida et al., 2014) .
| RESULTS AND DISCUSSION
All nasal and rectal swabs were tested using the pan-coronavirus (Table 2) . Using the HKU23-specific RTqPCR, two positives were detected including SA1354 identified as HKU23 by sequencing the pan-coronavirus RT-PCR assay amplicon and an additional positive result with a high Ct value of 37.6 from a nasal swab sample. None of the other nasal swabs had evidence of coronavirus RNA. Compared to the pan-coronavirus assay, the specific ECoV-and HKU23-specific assays detected one additional specimen that was weakly positive for each of these viruses ( Table 2 ).
The five pan-coronavirus PCR CoV-positive specimens had Ct ranging from 29.4 to 35.9 in either the ECoV or HKU23 specific assays. The pan-coronavirus RT-PCR was not sensitive at detecting specimens with Ct higher than 36 in the ECoV or HKU23 assays.
However, the results do demonstrate the importance of using the pan-coronavirus assay when investigating coronavirus activity in animal species in new geographic areas. Our initial focus was to explore for evidence of MERS-CoV infections in horses in Saudi Arabia and
Oman. None of the rectal swabs were positive for MERS-CoV RNA, but the application of the pan-coronavirus RT-PCR to these specimens revealed the presence of two other coronaviruses infecting horses in this region, that is ECoV and HKU23.
All seven horses from whom ECoV or HKU23 were detected were apparently healthy. The specimens positive for ECoV RNA all came from different horses at a horse breeding facility in Riyadh.
The two horses positive for HKU23 RNA were from Dammam and Qateef, Saudi Arabia, where horses were used for farming, and in
Dammam, also for breeding (Tables 1 and 2 ). In both cases, these F I G U R E 1 Phylogenetic analysis of equine coronavirus, human coronavirus OC43 and bovine coronavirus/dromedary camel coronavirus HKU23 cluster. The maximum likelihood phylogenetic tree rooted to HKU1 as an outgroup was generated using virus RdRp gene alignment of 934 nt by PhyML with approximate likelihood ratio test (aLRT) SH-like branch support. Sequences generated from this study are highlighted in red. GenBank accession numbers of are indicated in brackets. Colour figure can be viewed at wileyonlinelibrary.com] horses frequently came into contact with camels and other domestic livestock. HKU23 coronavirus is known to be endemic in camels (Woo et al., 2014) .
T A B L E 4 MERS-CoV serology results
Horse
We investigated for serologic evidence of MERS-CoV infections in the 243 horse sera using ppNT screening followed by endpoint titrations. Any sera positive at a screening reciprocal antibody titre of 20 in ppNT were confirmed using MN assay and PRNT assay using live MERS-CoV strain EMC. Possible serologic cross-reactions with ECoV and BCoV were evaluated in MN assays which are the most specific serological assays available. Of the 243 sera tested, only five (2%) had detectable MERS-CoV antibody in the MERSppNT assay at a screening titre of 20; four of these were from Saudi Arabia, and one was from Oman. The endpoint MERS-ppNT titres of these five sera ranged from 40 to 160 but only serum 9-2 which had the highest MERS-ppNT titre was positive in the MERS-CoV MN test (titre 20) (Table 4 ). In the confirmatory PRNT which is considered the "gold standard" serological test for MERS-CoV, horse serum 9-2 reduced plaque numbers by 90% (PRNT 90 ) up to a titre of 40. This serum was negative in ECoV and BCoV MN assays (Table 4 ). This serum was from a racing horse stable in Al-Qassem and may represent a rare example of transmission of MERS-CoV to horses or cross-reaction with another yet undocumented coronavirus infecting horses. This horse was not known to frequently come into contact with camels. Three of the other sera (serum ID nos 5.35; 5.41; 2.12) positive in the MERS-CoV ppNT assay had detectable ECoV MN antibody and one of these also had detectable BCoV MN antibody (Table 4) . Thus, these may well represent evidence of cross-reactive responses.
T A B L E 5 Cross-neutralization titres (denoted as reciprocal titres) for Middle East respiratory coronavirus (MERS-CoV), bovine coronavirus (BCoV) and equine coronavirus (ECoV) in hyperimmune or naturally infected sera known to be positive for different coronaviruses NRC772 -Rabbit antisera SARS S protein high titre 640 <20 <20 <20 <20
Mouse hepatitis virus(JHM strain) hyperimmunized mouse dam 1 1,778 c -neutralisation titre <20 <20 <20 <20
Mouse hepatitis virus(JHM strain) hyperimmunized mouse dam 2 363 c -neutralisation titre <20 <20 <20 <20
Mouse hepatitis virus(A59 strain)-infected mice 1,000 c -neutralization titre <20 <20 <20 <20
NRC774 -antisera for SARS coronavirus sero titre <10 <20 <20 <20 <20
NRC769 -Rabbit antisera to SARS S protein sero titre <10 <20 <20 <20 <20
Gamma coronavirus NR2515-Guina pig antiserum to infectious bronchitis virus 50,000 a <20 <20 <20 <20 7-3 <20 <20
7-4 <20 20 7-1 <20 <20
7-2 <20 <20
Al-Qassem 9 (Racing) 9-A3 20 <20
9-A4 <20 40 9-A5 <20 <20
9-B1 <20 <20
9-C1 20 20
9-C2 80 640
9-E1 <20 <20
9-E2 <20 <20 11-9 <20 320 11-11 <20 <20
11-12 <20 <20
11-13 <20 80
(Continues)
The extent of the serological cross-reactivity of MERS-CoV, ECoV and BCoV was systematically investigated. We did not have an isolate of HKU23 virus available for serological testing and BCoV was used as a virus that is genetically closely related to HKU23 with pairwise amino acid similarity of 94.1% in the spike protein gene, the determinant of antigenic cross-reaction in neutralization tests (Woo et al., 2014) . Horse sera obtained from the USA reported to be strongly reactive by ELISA (optical density ranging from 1.458 to 1.939) for ECoV showed high titre (>1,280) for ECoV in MN assay as expected, but also had high antibody titres (ranging from 160 to 1,280) in BCoV MN tests (Table 5) . As these horse sera were from horses in the "field," they may well have been exposed to multiple Table 5 . A dromedary serum from Kazakhstan, a region known to be free of MERS-CoV activity (Miguel et al., 2016) , had detectable antibody to BCoV (probably reflecting HKU23 or BCoV infection) and also to ECoV. We cannot conclude whether this reflects cross-reactivity or infection with BCoV, HKU23 and/or ECoV. None of the beta coronavirus immune sera to SARS-CoV or mouse hepatitis virus, nor immune sera to alpha or gamma coronaviruses gave cross-reactions in BCoV or ECoV MN assays (Table 5) . As had been previously reported, none of these dromedary sera cross-reacted with MERS-CoV (Hemida et al., 2014) .
Fifty-four horse sera from Saudi Arabia and Oman were selected to represent different collection locations, excluding those five sera previously reported to be MERS-CoV ppNT positive (Table 6 ). These sera were seronegative for MERS-CoV (as expected); 40 (74%) of them had detectable MN antibody to ECoV (titres ranging from <20 to 640; median 40), and 18 (33.3%) had MN antibodies to BCoV (titres ranging from <20 to 160; median <20). The reciprocal geometric mean antibody titres (assigning sera with titres <20 the value of 10 for computational purposes) for ECoV and BCoV were 44 and 25.5, respectively. There were twenty-four sera with undetectable antibody to BCoV with detectable ECoV antibody titres ranging from 20 to 640. The titres to ECoV were higher than or equal to titres to BCoV, with two exceptions where the titre to BCoV (20) was marginally higher than that with ECoV (Table 6 ). These results are compatible with the RT-PCR detection of ECoV in rectal swabs in horses and probably suggest that ECoV or a closely related virus is commonly infecting horses in many regions of the Arabian Peninsula.
Two of the five horses in whom ECoV RNA was detected by RTqPCR had low ECoV MN antibody titres (20) while the other three had titres ranging from 160 to 640 (Table 6 ). This may reflect virus shedding persists into convalescence or that re-infection of previously seropositive horses can occur.
The RTqPCR detection of two HKU23-like viruses indicates that HKU23 which is common in dromedaries in the region is also infecting horses. In the absence of an HKU23 isolate for use in neutralization tests and given the potential serological cross-reactivity between these three viruses, it is difficult to conclude how com- | 2101 MERS-CoV did not result in virus replication or seroconversion (Adney et al., 2016) .
In conclusion, the serological data suggest that lineage A betacoronaviruses are commonly infecting horses in Saudi Arabia and Oman but antibody cross-reactions between these viruses do not permit us to use serological data alone to identify which coronaviruses are causing these infections. RT-PCR detection of ECoV and HKU23 in equine swabs confirms the circulation of these two viruses in horses in Saudi Arabia. Cocirculation of related viruses may provide potential for recombination, a potential means of generating genetic diversity and facilitating host jumps in coronaviruses. This is the first report of HKU23 being detected in horses and the first detection of ECoV in Asia outside of Japan.
